Puma Biotechnology (PBYI) Assets (2017 - 2025)
Historic Assets for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $202.9 million.
- Puma Biotechnology's Assets fell 809.12% to $202.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $202.9 million, marking a year-over-year decrease of 809.12%. This contributed to the annual value of $213.3 million for FY2024, which is 745.9% down from last year.
- Latest data reveals that Puma Biotechnology reported Assets of $202.9 million as of Q3 2025, which was down 809.12% from $194.9 million recorded in Q2 2025.
- Puma Biotechnology's Assets' 5-year high stood at $260.0 million during Q2 2021, with a 5-year trough of $193.7 million in Q2 2022.
- In the last 5 years, Puma Biotechnology's Assets had a median value of $205.0 million in 2024 and averaged $213.9 million.
- Per our database at Business Quant, Puma Biotechnology's Assets skyrocketed by 1468.99% in 2021 and then tumbled by 2551.83% in 2022.
- Over the past 5 years, Puma Biotechnology's Assets (Quarter) stood at $226.6 million in 2021, then decreased by 2.0% to $222.1 million in 2022, then increased by 3.81% to $230.5 million in 2023, then fell by 7.46% to $213.3 million in 2024, then fell by 4.91% to $202.9 million in 2025.
- Its Assets stands at $202.9 million for Q3 2025, versus $194.9 million for Q2 2025 and $196.2 million for Q1 2025.